Skip to main content
. 2023 Jul 31;22:195. doi: 10.1186/s12933-023-01937-x

Table 2.

Current unmet needs and potential future directions to improve CMR management

Unmet needs Future directions
Novel medications with CMR benefits

• Identification of druggable CMR connectors

• Further efficacy and safety data of novel therapies

Combination therapy strategy

• Better understanding of drug mechanisms of action

• Outcomes trials testing combination therapies

Integrated management of CMR disease • Multidisciplinary approach
Risk-stratified personalized care

• Risk score validation for individualized prognostication

• Clinical trials in specific populations (women/young/primary prevention)

Drug prioritization • Head-to-head drug comparative trials

CMR, cardio-metabolic-renal